Publications by authors named "D Legoupil"

Claim this Profile
B
B-cell involvement in immune checkpoint inhibitor-induced lichen planus: a comparative analysis with non-drug-related lichen planus.
Alice Tison, Delphine Legoupil, Marion Le Rochais, Patrice Hémon, Nathan Foulquier

J Invest Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of adjuvant therapies in stage III/IV melanoma: Insights from the French RIC-MEL cohort.
M Vuillemey, T Goronflot, P Celerier, D Legoupil, L Misery

J Eur Acad Dermatol Venereol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastases from Merkel cell carcinoma: A nationwide retrospective study.
Raphaëlle Caillot, Astrid Blom, Céleste Lebbé, Laetitia Da Meda, Marie Boileau, Delphine Legoupil

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitors.
Karim Amrane, Pierre Le Noac'h, Patrice Hemon, Ronan Abgral, Coline Le Meur, Delphine Legoupil

Melanoma Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to stop immunotherapy for advanced melanoma: the emulated target trials.
Mathilde Amiot, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sophie Dalac, Delphine Legoupil

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis